Information  X 
Enter a valid email address

Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC

By BFN News | 09:40 AM | Friday 09 November, 2018


Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and cut its price target to 6600p (from 6800p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk

a d v e r t i s e m e n t